CORE--TISSUE CULTURE

$258,189P01FY2000HLNIH

University Of Rochester, Rochester NY

Investigators

Linked publications & trials

Paper 30538176 Paper 28458726 Paper 28093865 Paper 27368167 Paper 27197088 Paper 27042237 Paper 26626697 Paper 26605493 Paper 26376642 Paper 26342259 Paper 26287622 Paper 26219404 Paper 26138722 Paper 26091091 Paper 25768202 Paper 25674729 Paper 25582838 Paper 25567338 Paper 25278585 Paper 25229138 Paper 25186818 Paper 25110459 Paper 25003200 Paper 24853753 Paper 24850320 Paper 24733886 Paper 24586641 Paper 24480897 Paper 24384944 Paper 24113789 Paper 24048341 Paper 23933892 Paper 23788664 Paper 23701383 Paper 23481422 Paper 23462566 Paper 23446563 Paper 22922958 Paper 22711877 Paper 22689994 Paper 22683734 Paper 22104111 Paper 21806925 Paper 21653902 Paper 21532911 Paper 21277237 Paper 21037096 Paper 20704280 Paper 20526279 Paper 20473350 Paper 20454973 Paper 20363969 Paper 20055917 Paper 19995397 Paper 19864611 Paper 19580776 Paper 19580775 Paper 19542447 Paper 19486904 Paper 19468960 Paper 19403602 Paper 19383446 Paper 19280342 Paper 19246218 Paper 19244161 Paper 19194913 Paper 19184539 Paper 19150332 Paper 19134480 Paper 19134479 Paper 19095798 Paper 18829897 Paper 18641276 Paper 18592294 Paper 18487296 Paper 18339756 Paper 18317930 Paper 17915247 Paper 17716693 Paper 17704289 Paper 17333319 Paper 17172469 Paper 17071667 Paper 17029031 Paper 17012330 Paper 16766643 Paper 16308467 Paper 16126813 Paper 16100282 Paper 16020081 Paper 15879471 Paper 15574709 Paper 15361413 Paper 15361412 Paper 15331369 Paper 15315955 Paper 15280097 Paper 15153519 Paper 14962843 Paper 14962004

Abstract

Cultured cells (primarily but not exclusively endothelial cells) are required by all four projects of this program project. This core will primarily serve the requirement of the three Rochester projects, although there will be some ongoing technology transfer in both directions between the core and Dr. Hamner's project. We anticipate that by combining much of the routine technical support for the culture systems we will be able to effect a significant saving in cost and effort. However, the major rationale for this core facility resides in our experience from the present project period that, for endothelial cells, there are stringent and differing requirements for growth the different ell types (HUVECs, HMEC-1s, BAECs) in the various growth configurations-microchannels, microslides, parallel plate systems etc.

View original record on NIH RePORTER →